DocuSign, Inc. (NASDAQ:DOCU) CFO Blake Jeffrey Grayson Sells 8,000 Shares

DocuSign, Inc. (NASDAQ:DOCU) CFO Blake Jeffrey Grayson sold 8,000 shares of the company’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $86.90, for a total transaction of $695,200.00. Following the transaction, the chief financial officer now owns 77,851 shares of the company’s stock, valued at approximately $6,765,251.90. This trade represents a 9.32 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Blake Jeffrey Grayson also recently made the following trade(s):

• On Wednesday, December 18th, Blake Jeffrey Grayson sold 15,588 shares of DocuSign stock. The shares were sold at an average price of $97.78, for a total transaction of $1,524,194.64.
• On Monday, December 16th, Blake Jeffrey Grayson sold 8,000 shares of DocuSign stock. The shares were sold at an average price of $94.77, for a total transaction of $758,160.00.

DocuSign Stock Performance

NASDAQ:DOCU opened at $87.34 on Wednesday. The stock has a market capitalization of $17.64 billion, a P/E ratio of 18.01, a PEG ratio of 7.56 and a beta of 0.89. The company has a 50 day moving average price of $92.44 and a 200 day moving average price of $75.87. DocuSign, Inc. has a fifty-two week low of $48.70 and a fifty-two week high of $107.86.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on DOCU shares. Morgan Stanley upped their price objective on shares of DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. HSBC reaffirmed a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. JMP Securities reissued a “market outperform” rating and issued a $124.00 price target on shares of DocuSign in a research note on Tuesday, January 7th. Robert W. Baird increased their price target on shares of DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $90.00 price target (up previously from $57.00) on shares of DocuSign in a research note on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $92.45.

Institutional Investors Weigh In On DocuSign

A number of hedge funds have recently added to or reduced their stakes in DOCU. Exchange Traded Concepts LLC lifted its holdings in DocuSign by 2,689.1% during the 3rd quarter. Exchange Traded Concepts LLC now owns 3,849 shares of the company’s stock worth $239,000 after buying an additional 3,711 shares in the last quarter. Creative Planning lifted its holdings in DocuSign by 5.6% during the 3rd quarter. Creative Planning now owns 14,453 shares of the company’s stock worth $897,000 after buying an additional 766 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in DocuSign by 3.3% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 41,436 shares of the company’s stock worth $2,573,000 after buying an additional 1,341 shares in the last quarter. V Square Quantitative Management LLC lifted its holdings in DocuSign by 6.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 3,019 shares of the company’s stock worth $187,000 after buying an additional 172 shares in the last quarter. Finally, Blue Trust Inc. lifted its holdings in DocuSign by 1,355.9% during the 3rd quarter. Blue Trust Inc. now owns 1,485 shares of the company’s stock worth $92,000 after buying an additional 1,383 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.